Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
379.50    6.00 (1.61%)
Bid:
380.50
Ask:
382.50
Spread: 2.00 (0.526%)
Market Cap: £1.72b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Interim Management Statement

6 May 2008 07:00

HgCapital Trust plc - Interim Management Statement 6th May 2008

HgCapital Trust plc ("the Company"), today issues its Interim Management Statement in accordance with FSA Disclosure and Transparency Rule 4.3. This statement relates to the period from 1st January 2008 to 6 May 2008 and incorporates the Company's calculation of its net asset value at the end of April, in the same form as is issued following the end of each month. The Net asset value (NAV) at April is based on the valuations of unquoted investments as at 31st December, as set out in the annual report, but is adjusted for realisations, exchange rates, changes in value of quoted securities, and net revenues during the period.

Investment activity during the period

Since the end of the year the Company has completed one further realisation (Classic Copyright), in addition to completing the realisations described in the annual report and received some deferred proceeds, totalling ‚£61.8 million cash proceeds for the Company. One acquisition (Casa Reha) which is described in the annual report has been completed with the Company investing ¢â€š¬ 13.4 million.

Performance since the year-end

Since 31st December the total return (NAV plus dividend) was 9.0%, compared with the negative total return of -4.2% of the FTSE All-Share Index. The Company's share price at the end of April was 881.0 pence, a discount of 12.6% against the NAV (on an ex-div basis) of 1,007.82 pence. The Company's share price (on a total return basis) increased by 16.0% over the four months to 30th April while the FTSE All-Share Index and FTSE SmallCap Index fell by 4.2% and 7.0% respectively on a total return basis.

Roger Mountford, the Chairman of the Company, said:

"Despite the volatility in financial markets HgCapital Trust has achieved a good start to the year, completing a series of realisations at prices materially above their valuations at 31st December 2007. As the difficulties of financial markets feed into the wider economy it becomes all the more valuable that our manager, HgCapital, is represented on the board of every material investment in the portfolio and therefore able to monitor closely and, where necessary, ensure that management reacts to changes in trading conditions and performance. Our manager has reported that so far only a small number of companies within the portfolio appear to be suffering from changes in trading conditions in their respective markets, with the majority on or ahead of plan at this stage.

"The recent falls in equity markets have created a better environment for purchasers able to identify sound businesses, though as expected this is not yet recognised by all vendors of private businesses. The Company enters this part of the investment cycle with substantial resources available for investment and, in the Board's view, remains an attractive vehicle for investors seeking long-term growth."

Investment objective

HgCapital Trust plc gives the investor access to a private equity portfolio run by an experienced and well-resourced Manager that makes investments in fast growing companies over a number of geographies and sectors.

The objective of the Company is to provide shareholders with long-term capital appreciation in excess of the FTSE All-Share Index by investing in unquoted companies. The Company provides investors with exposure to a diversified portfolio of private equity investments primarily in the UK and Continental Europe.

The Company's Benchmark is the FTSE All-Share Index.

Performance

All information is at 30th April 2008 and is unaudited.

Performance at month end with net income reinvested

One month Three One year Three years Five years months Net asset value 2.1% 5.5% 35.9% 120.0% 231.4% Share price 6.1% 5.5% 4.9% 91.5% 335.8% FTSE All-Share 6.3% 4.9% -4.3% 42.7% 93.1%Index

Sources: HgCapital, Capital Economics

ResultsAt 30th April 2008Net asset value:* 1,007.82p Share price: 881.00p Discount 12.6% Total assets: ‚£253.8m Net yield: 2.8% Gearing: Nil% Ordinary shares in issue: 25,186,755

* includes 4 months net revenue of 22.66p and is after providing for payment of the dividend of 25p payable on 12 May 2008 and after providing for the carried interest

Unaudited Net Asset Value per Share

The investment portfolio has not been revalued at 30th April 2008. However, it is calculated on the basis of the NAV at 31st December 2007 adjusted to reflect the purchases and sales of investments, currency movements and bid values in respect of listed investments. The unaudited net asset value at 30th April 2008 was 1,007.82 pence per share by comparison with 948.20 pence at 31st December 2007, an increase of 6.3%. This is after a carried interest liability of 21.3 pence included in the balance sheet.

On the 17th March 2008, the Board declared a dividend of 25 pence per share. This is payable on the 12th May 2008 and after providing is included as a liability in the balance sheet as at the 30th April 2008.

Net revenue for the four months to 30th April 2008 was 22.66p.

Balance Sheet

At the 30th April 2008, the Company's balance sheet was comprised as follows:

‚£m % Unquoted investments 127,540 50.2 Quoted investments 1,986 0.8 ----------- ------ Total investment portfolio 129,526 51.0 Cash/Gilts 123,216 48.6 Other net assets 1,095 0.4 ----------- ------ Net asset value 253,837 100.0Investments

During the period, the Company made one new investment in Casa Reha, one of the leading German private nursing home groups, with an enterprise value of ¢â€š¬327 million. The company invested ¢â€š¬13.4 million.

Realisations

During the period, the Manager completed the sales of Hofmann Menƒ¼, The Sanctuary Spa, Clarion Events and Classic Copyright, as well as selling its remaining shares in Xyratex and PRA and receiving some deferred proceeds, returning a total of ‚£61.8 million to the Company.

PortfolioTen Largest InvestmentsCompany Total Assets % Sector VISMA 5.8 TMT Casa Reha 4.2 Healthcare Voyage Heathcare 3.5 Healthcare Atlas t/a Atlas 3.2 Services Interactive Addison 3.2 TMT BMFCO UA t/a Fabory 3.1 Services Mondo Minerals Co-op 3.1 Industrials Sporting Index 2.8 Consumer & Leisure SLV Electronics 2.7 Industrials SHL 2.6 Services Total 34.2 Sector Total Assets % TMT 13.2 Industrials 9.3 Consumer & Leisure 8.8 Healthcare 8.4 Services 9.0 Renewable Energy 1.6 Other 0.7 Fixed Interest 44.8 Net current assets 0.4 Cash 3.8 Total 100.0

This statement is a general description of the financial position and performance of the Company for the period from 1st January 2008 to 6 May 2008. It does not contain any profit forecast or forward looking information. Future performance and share price is likely to be affected by a number of factors, including (but not limited to) general economic and market conditions and specific factors affecting the financial performance or prospects of individual investments within the Company's portfolio.

vendor
Date   Source Headline
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution
29th Apr 20221:38 pmRNSDirectorate Change
11th Apr 20223:00 pmRNSHg announces investment in LucaNet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.